Analytical Data
-
Gene name
TCAP
- Application
-
Alternative Names
Titin cap protein
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O15273
-
Expression Region
1-167aa
-
Molecular Weight
46.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of TCAP (Tenascin-C Associated Peptide) recombinant protein has gained significant interest due to its potential role in various biological processes and therapeutic applications. Tenascin-C is an extracellular matrix protein involved in cell adhesion, migration, and tissue remodeling, particularly during development and inflammation. Disruptions in the expression or function of Tenascin-C have been linked to several pathological conditions, including cancer, wound healing, and neurodegenerative diseases. Given its multifaceted roles, researchers are keen to explore the properties and functionalities of TCAP as a recombinant protein. By producing TCAP in a controlled laboratory setting, scientists aim to investigate its molecular interactions, mechanistic pathways, and potential as a biomarker or therapeutic target. Moreover, recombinant TCAP may serve as a promising tool for studying its influence on cell behavior and the extracellular matrix, paving the way for innovative treatment strategies in regenerative medicine and oncology. In summary, the investigation of TCAP recombinant protein is essential for understanding its biological significance and its applications in health and disease management.
